Unknown

Dataset Information

0

Lysine-specific demethylase 1 is a therapeutic target for fetal hemoglobin induction.


ABSTRACT: Enhanced fetal ?-globin synthesis alleviates symptoms of ?-globinopathies such as sickle cell disease and ?-thalassemia, but current ?-globin-inducing drugs offer limited beneficial effects. We show here that lysine-specific demethylase 1 (LSD1) inhibition by RNAi in human erythroid cells or by the monoamine oxidase inhibitor tranylcypromine in human erythroid cells or ?-type globin-transgenic mice enhances ?-globin expression. LSD1 is thus a promising therapeutic target for ?-globin induction, and tranylcypromine may serve as a lead compound for the development of a new ?-globin inducer.

SUBMITTER: Shi L 

PROVIDER: S-EPMC5512162 | biostudies-literature | 2013 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications

Lysine-specific demethylase 1 is a therapeutic target for fetal hemoglobin induction.

Shi Lihong L   Cui Shuaiying S   Engel James D JD   Tanabe Osamu O  

Nature medicine 20130217 3


Enhanced fetal γ-globin synthesis alleviates symptoms of β-globinopathies such as sickle cell disease and β-thalassemia, but current γ-globin-inducing drugs offer limited beneficial effects. We show here that lysine-specific demethylase 1 (LSD1) inhibition by RNAi in human erythroid cells or by the monoamine oxidase inhibitor tranylcypromine in human erythroid cells or β-type globin-transgenic mice enhances γ-globin expression. LSD1 is thus a promising therapeutic target for γ-globin induction,  ...[more]

Similar Datasets

| S-EPMC6060236 | biostudies-literature
| S-EPMC6029722 | biostudies-literature
| S-EPMC7513387 | biostudies-literature
2016-10-27 | GSE81557 | GEO
2010-07-29 | E-GEOD-22369 | biostudies-arrayexpress
| S-EPMC6348980 | biostudies-literature
| S-EPMC7645986 | biostudies-literature
2010-06-28 | GSE22369 | GEO
| S-EPMC7673473 | biostudies-literature
| S-EPMC5357761 | biostudies-literature